204 related articles for article (PubMed ID: 34339730)
1. Abnormality in the NK-cell population is prolonged in severe COVID-19 patients.
Leem G; Cheon S; Lee H; Choi SJ; Jeong S; Kim ES; Jeong HW; Jeong H; Park SH; Kim YS; Shin EC
J Allergy Clin Immunol; 2021 Oct; 148(4):996-1006.e18. PubMed ID: 34339730
[TBL] [Abstract][Full Text] [Related]
2. Expansion of CD56
Casado JL; Moraga E; Vizcarra P; Velasco H; Martín-Hondarza A; Haemmerle J; Gómez S; Quereda C; Vallejo A
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062250
[TBL] [Abstract][Full Text] [Related]
3. The early expansion of anergic NKG2A
Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
[TBL] [Abstract][Full Text] [Related]
4. A New Hope for CD56
Forconi CS; Oduor CI; Oluoch PO; Ong'echa JM; Münz C; Bailey JA; Moormann AM
Front Cell Infect Microbiol; 2020; 10():162. PubMed ID: 32373555
[TBL] [Abstract][Full Text] [Related]
5. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
6. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
Carsetti R; Zaffina S; Piano Mortari E; Terreri S; Corrente F; Capponi C; Palomba P; Mirabella M; Cascioli S; Palange P; Cuccaro I; Milito C; Zumla A; Maeurer M; Camisa V; Vinci MR; Santoro A; Cimini E; Marchioni L; Nicastri E; Palmieri F; Agrati C; Ippolito G; Porzio O; Concato C; Onetti Muda A; Raponi M; Quintarelli C; Quinti I; Locatelli F
Front Immunol; 2020; 11():610300. PubMed ID: 33391280
[TBL] [Abstract][Full Text] [Related]
7. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells.
Witkowski M; Tizian C; Ferreira-Gomes M; Niemeyer D; Jones TC; Heinrich F; Frischbutter S; Angermair S; Hohnstein T; Mattiola I; Nawrath P; McEwen S; Zocche S; Viviano E; Heinz GA; Maurer M; Kölsch U; Chua RL; Aschman T; Meisel C; Radke J; Sawitzki B; Roehmel J; Allers K; Moos V; Schneider T; Hanitsch L; Mall MA; Conrad C; Radbruch H; Duerr CU; Trapani JA; Marcenaro E; Kallinich T; Corman VM; Kurth F; Sander LE; Drosten C; Treskatsch S; Durek P; Kruglov A; Radbruch A; Mashreghi MF; Diefenbach A
Nature; 2021 Dec; 600(7888):295-301. PubMed ID: 34695836
[TBL] [Abstract][Full Text] [Related]
8. Elevated Exhaustion Levels of NK and CD8
Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
Front Immunol; 2020; 11():580237. PubMed ID: 33154753
[TBL] [Abstract][Full Text] [Related]
9. Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.
Krämer B; Knoll R; Bonaguro L; ToVinh M; Raabe J; Astaburuaga-García R; Schulte-Schrepping J; Kaiser KM; Rieke GJ; Bischoff J; Monin MB; Hoffmeister C; Schlabe S; De Domenico E; Reusch N; Händler K; Reynolds G; Blüthgen N; Hack G; Finnemann C; Nischalke HD; Strassburg CP; Stephenson E; Su Y; Gardner L; Yuan D; Chen D; Goldman J; Rosenstiel P; Schmidt SV; Latz E; Hrusovsky K; Ball AJ; Johnson JM; Koenig PA; Schmidt FI; Haniffa M; Heath JR; Kümmerer BM; Keitel V; Jensen B; Stubbemann P; Kurth F; Sander LE; Sawitzki B; ; Aschenbrenner AC; Schultze JL; Nattermann J
Immunity; 2021 Nov; 54(11):2650-2669.e14. PubMed ID: 34592166
[TBL] [Abstract][Full Text] [Related]
10. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Huth TK; Staines D; Marshall-Gradisnik S
J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
[TBL] [Abstract][Full Text] [Related]
11. Unique immunological profile in patients with COVID-19.
Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
[TBL] [Abstract][Full Text] [Related]
12. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19.
Bergantini L; d'Alessandro M; Cameli P; Cavallaro D; Gangi S; Cekorja B; Sestini P; Bargagli E
Cells; 2021 Nov; 10(11):. PubMed ID: 34831404
[TBL] [Abstract][Full Text] [Related]
13. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice.
Ghasemzadeh M; Ghasemzadeh A; Hosseini E
Hum Immunol; 2022 Jan; 83(1):86-98. PubMed ID: 34583856
[TBL] [Abstract][Full Text] [Related]
14. Immune Dysfunctions of CD56
Cao WJ; Zhang XC; Wan LY; Li QY; Mu XY; Guo AL; Zhou MJ; Shen LL; Zhang C; Fan X; Jiao YM; Xu RN; Zhou CB; Yuan JH; Wang SQ; Wang FS; Song JW
Front Immunol; 2021; 12():811091. PubMed ID: 35069597
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Natural Killer Cells, CD56+ CD16+ Natural Killer Cells,
Radandish M; Esmaeil N; Khorvash F; Andalib A
Viral Immunol; 2022 Nov; 35(9):616-628. PubMed ID: 36099205
[TBL] [Abstract][Full Text] [Related]
16. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
[TBL] [Abstract][Full Text] [Related]
17. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.
Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C
Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357
[TBL] [Abstract][Full Text] [Related]
18. Human peripheral blood DNAM-1
Stannard KA; Lemoine S; Waterhouse NJ; Vari F; Chatenoud L; Gandhi MK; Martinet L; Smyth MJ; Guillerey C
Blood Adv; 2019 Jun; 3(11):1681-1694. PubMed ID: 31167820
[TBL] [Abstract][Full Text] [Related]
19. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
[TBL] [Abstract][Full Text] [Related]
20. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
